PACIRA BIOSCIENCES INC (PCRX) Stock News

USA - NASDAQ:PCRX - US6951271005 - Common Stock

22.87 USD

+0.1 (+0.44%)

Last: 10/17/2025, 8:00:00 PM

22.87 USD

0 (0%)

After Hours: 10/17/2025, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PCRX Latest News, Press Relases and Analysis

All

Press Releases

16 days ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 days ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: The Motley Fool

Pacira (PCRX) Q2 Revenue Rises 1.7%

2 months ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings

2 months ago - By: Zacks Investment Research - Mentions: RCUS

Pacira (PCRX) Tops Q2 Earnings Estimates

2 months ago - By: Pacira BioSciences

Pacira BioSciences Reports Second Quarter 2025 Financial Results

2 months ago - By: Pacira BioSciences

Pacira BioSciences Reports Second Quarter 2025 Financial Results

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

3 months ago - By: Benzinga

Insights Ahead: Pacira BioSciences's Quarterly Earnings

3 months ago - By: Pacira BioSciences

Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025

3 months ago - By: Pacira BioSciences

Pacira BioSciences Announces Strategic Collaboration to Significantly Expand ZILRETTA Promotional Efforts

3 months ago - By: Shareholders Foundation, Inc.

Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit

3 months ago - By: Yahoo Finance

Pacira BioSciences Gene Therapy Shows Sustained Knee Osteoarthritis Improvement

4 months ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: ACCESS Newswire - Mentions: SUI MODV IAS

Lifshitz Law PLLC Announces Investigations of Sun Communities, Inc. (NYSE: SUI), Pacira Biosciences, Inc. (NASDAQ: PCRX), ModivCare, Inc. (NASDAQ: MODV), and Integral Ad Science Holding Corp. (NASDAQ: IAS)

4 months ago - By: Pacira BioSciences

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025

4 months ago - By: Pacira BioSciences

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025

4 months ago - By: Bragar Eagel & Squire

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

4 months ago - By: ACCESS Newswire - Mentions: BOOM SUI MODV

Lifshitz Law PLLC Announces Investigations of DMC Global Inc. (NASDAQ: BOOM), Sun Communities, Inc. (NYSE: SUI), Pacira Biosciences, Inc. (NASDAQ: PCRX), and ModivCare, Inc. (NASDAQ: MODV)

4 months ago - By: Pacira BioSciences

Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee

5 months ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Pacira BioSciences

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Grabar Law Office - Mentions: DV NSSC TMCI

Grabar Law Office Investigates Claims on Behalf of Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); NAPCO Securities Technologies, Inc. (NASDAQ: NSSC); Pacira Biosciences, Inc. (NASDAQ: PCRX); and Treace Medical Concepts, Inc. (NASDAQ: TMCI)

5 months ago - By: Pacira BioSciences

Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee

5 months ago - By: Pacira BioSciences

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

5 months ago - By: Pacira BioSciences

Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences

5 months ago - By: Shareholders Foundation, Inc.

Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation

5 months ago - By: Zacks Investment Research - Mentions: BEAM ADMA

Pacira BioSciences Q1 Earnings Beat, Revenues Miss Estimates